Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-10 | Amended | $35,219,000 | $9,119,000 | Equity Only | 06b | SEC link |
| 2024-05-30 | Amended | $26,100,000 | $5,055,994 | Equity Only | 06b | SEC link |
| 2023-06-09 | Amended | $21,044,006 | $5,120,000 | Equity Only | 06b | SEC link |
| 2022-09-14 | Amended | $15,924,006 | $9,424,006 | Equity Only | 06b | SEC link |
| 2021-07-30 | Amended | $10,091,006 | Unknown | Equity Only | SEC link | |
| 2019-09-18 | Amended | $6,500,000 | $4,056,500 | Equity Only | 06b | SEC link |
| 2019-06-18 | Amended | $2,443,500 | $1,524,500 | Equity Only | 06b | SEC link |
| 2018-06-08 | New | $919,000 | $919,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Stephen Badylak | Director, Executive |
| Katie Collins | Director, Executive |
| Jenna Dziki | Executive |
| Paul F. Fagan | Director, Executive |
| George Hussey | Executive |
| Lindsey Saldin | Executive |
| Christine Sheehy | Executive |